Skip to content

Functional MRI-Guided TMS Treatment over the Supplementary Motor Area of Psychomotor Retardation in Major Depressive Disorder

Functional MRI-Guided TMS Treatment over the Supplementary Motor Area of Psychomotor Retardation in Major Depressive Disorder

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114926
Enrollment
Unknown
Registered
2025-12-19
Start date
2026-01-05
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retardation major depressive disorder

Interventions

Supplementary Motor Area group:Supplementary Motor Area TMS
DLPFC group:DLPFC TMS
Healthy control group:NA

Sponsors

Beijing Anding Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: MDD: 1. Patients aged 18 to 65 years (inclusive) who are outpatients or inpatients, regardless of gender. 2. In accordance with the diagnostic criteria for Major Depressive Disorder (MDD) as outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5); 3. Hamilton Depression Scale, HAMD-17 >=14; 4. Both first-episode and recurrent cases; 5. Patients with first-episode who are drug-naïve, or who have discontinued medication for 2 weeks prior to enrollment, or who have been on a stable medication regimen for 2 weeks prior to enrollment; 6. HAMD-8th score >=1; 7. Be able to understand and voluntarily agree to participate in this study, and to comply with the treatment procedures. Be willing to sign the informed consent form; HC: 1. Aged 18 to 65 years (inclusive) who are outpatients or inpatients, regardless of gender. 2. Primary school education or above, able to understand the research content; 3. Had no history of somatic diseases in the cardiovascular, respiratory, digestive, renal, endocrine, or hematological systems. 4. No history of psychiatric disorders. 5. Be able to understand and voluntarily agree to participate in this study, and to comply with the treatment procedures. Be willing to sign the informed consent form;

Exclusion criteria

Exclusion criteria: MDD: 1. Current or past diagnosis of another mental disorder that meets DSM-5 criteria; 2. Subjects who have participated in any interventional clinical trials in the past 3 months. 3. Excessive head motion during the fMRI scan (i.e., translation greater than 3 mm or rotation greater than 3 degrees, with a mean framewise displacement greater than 0.8 mm). 4. Failed to complete the scan due to other reasons, such as claustrophobia; 5. MoCA score =2; 7. Serious organic disease or history of organic disease. HC: 1. Presents with a psychiatric disorder. 2. History of impaired consciousness, or psychiatric disorders such as schizophrenia, bipolar disorder, depressive disorder, or personality changes. 3. Family history of genetic diseases.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Scale ;

Secondary

MeasureTime frame
COLUMBIA-SUICIDE SEVERITY RATING SCALE (C-SSRS);Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR);Young Mania Rating Scale (YMRS);Hamilton Anxiety Rating Scale (HAMA);

Countries

China

Contacts

Public ContactZang Zhenxiang

Beijing Anding Hospital, Capital Medical University

zangzx416@gmail.com+86 10 5834 0269

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026